Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

This article reports an update to the protocol of the IMASOY trial, which was prospectively registered on clinicaltrials.gov (NCT04110340) in October 2019.

Original publication

DOI

10.1186/s13063-024-08302-7

Type

Journal

Trials

Publication Date

07/2024

Volume

25

Addresses

Institut Pasteur de Madagascar, Antananarivo, Madagascar.

Keywords

Animals, Humans, Plague, Ciprofloxacin, Aminoglycosides, Anti-Bacterial Agents, Treatment Outcome, Drug Therapy, Combination, Randomized Controlled Trials as Topic, Equivalence Trials as Topic